CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Cancer Network
Original article

<![CDATA[NCCN Guidelines Strengthen MRD Testing Recommendations in Multiple Myeloma]]>

RegulatoryPositive
AI Analysis

Summary

The NCCN updated its guidelines for multiple myeloma to include a dedicated MRD testing framework and expanded MRD assessment timepoints. This represents a routine guideline update affecting clinical practice standards.

Importance:4/10
Sentiment:
0.50
multiple myelomaMRD testingclinical guidelinesNCCN
Related Companies

Read the original article

Published by Cancer Network on September 18, 2026 3:30 PM

Read Original